This article from Sifted features the challenges and innovations in clinical trials, focusing on the high costs, inefficiencies, and failure rates in drug development, particularly in oncology.
It highlights how some of our portfolio companies are leveraging AI and real-world data (RWD) to revolutionize trials by improving efficiency, enabling personalized treatments, and reducing costs. Companies like Concr, Risklick, BC Platforms and Altis Labs use technologies like digital twins, AI-powered protocol design, computational imaging and trusted research environments for data sharing to streamline processes, predict treatment outcomes, and ensure compliance with regulations. Dr. Heidi Nauwelaerts, Debiopharm’s Head of Clinical Development, emphasizes the need for collaboration and innovation to streamline clinical development, ensuring faster, more patient-centric, and successful trials.
Discover more here.